A lack of glove changes at COVID-19 testing centers in Belgium led to major cross-contamination of samples and a high rate of false positive results. This was the finding of research that was presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Li
They also visited the sites to assess the personnel.
Site visits identified the lack of glove changes between patients as being the source of cross-contamination. This included managers being tasked with telling every staff member who swabbed patients about the importance of glove changing and test centers being contacted if there was a spike in their false positive rate.
Mr. Slechten says: “Nasopharyngeal sampling involves close contact between the hand of the health professional, the patient and sample tube. Therefore, it is essential to change gloves between each patient.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
BCG Vaccine for Tuberculosis Offers Covid-19 Protection, Study SuggestsA widely used tuberculosis vaccine protected people with type 1 diabetes from Covid-19, according to a study, further illustrating the potential immune-enhancing powers of the BCG shot
Lire la suite »
How to Assess Covid-19 Risks After Easing of CDC GuidelinesThe easing of federal Covid-19 guidelines places more responsibility on individuals. Here is what doctors recommend.
Lire la suite »
What You Need to Know About the New Omicron-Specific Moderna COVID-19 BoosterIt was just authorized in the U.K., for starters.
Lire la suite »
While CDC modifies its COVID-19 recommendations, Lake County community transmission level remains highLake County remains at a high community level of transmission for COVID-19 based on the number of new cases and hospitalizations.
Lire la suite »
Pfizer CEO tests positive for COVID-19Bourla said he has received four shots of Comirnaty, the COVID-19 vaccine developed by Pfizer and BioNTech.
Lire la suite »